Injectable Synthetic Beta-Tricalcium Phosphate/Calcium Sulfate (GeneX) for the Management of Contained Defects Following Curettage of Benign Bone Tumours

Benign and low-grade malignant bone tumours are often treated with curettage and filling of the resultant defect using any of a number of materials, including autologous bone grafts, allografts, or synthetic materials. The objective of this study was to report our experience using a synthetic bone g...

Descripción completa

Detalles Bibliográficos
Autores principales: Razii, Nima, Docherty, Laura M., Halai, Mansur, Mahendra, Ashish, Gupta, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137257/
https://www.ncbi.nlm.nih.gov/pubmed/37185394
http://dx.doi.org/10.3390/curroncol30040281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137257/
https://www.ncbi.nlm.nih.gov/pubmed/37185394
http://dx.doi.org/10.3390/curroncol30040281

Ejemplares similares